Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease

Abstract Premature immune ageing, including thymic atrophy, is observed in patients with chronic kidney disease (CKD). Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23), which are mineral and bone disorder (MBD)-related factors, affect immune cells and possibly cause thymic atrophy....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kenichiro Iio, Daijiro Kabata, Rei Iio, Yosuke Imai, Masaki Hatanaka, Hiroki Omori, Yoshihiko Hoshida, Yukihiko Saeki, Ayumi Shintani, Takayuki Hamano, Yoshitaka Isaka, Yutaka Ando
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/78e139fff6524f55999681e7229fc591
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:78e139fff6524f55999681e7229fc591
record_format dspace
spelling oai:doaj.org-article:78e139fff6524f55999681e7229fc5912021-12-02T15:08:31ZParathyroid hormone and premature thymus ageing in patients with chronic kidney disease10.1038/s41598-018-37511-92045-2322https://doaj.org/article/78e139fff6524f55999681e7229fc5912019-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-37511-9https://doaj.org/toc/2045-2322Abstract Premature immune ageing, including thymic atrophy, is observed in patients with chronic kidney disease (CKD). Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23), which are mineral and bone disorder (MBD)-related factors, affect immune cells and possibly cause thymic atrophy. We examined the cross-sectional association between thymic atrophy, evaluated as the number of CD3+CD4+CD45RA+CD31+ cells [recent thymic emigrants (RTE)/μL], and MBD-related factors [(serum PTH, FGF23, and alkaline phosphatase (ALP) level] in 125 patients with non-dialysis dependent CKD. Median estimated glomerular filtration rate (eGFR) was 17 mL/min/1.73 m2. Older age (r = −0.46), male sex (r = −0.34), lower eGFR (r = 0.27), lower serum-corrected calcium (r = 0.27), higher PTH (r = −0.36), and higher ALP level (r = −0.20) were identified as determinants of lower number of RTE. In contrast, serum concentrations of FGF23 and phosphorus were not correlated with RTE. Multivariate non-linear regression analysis indicated a negative association between serum PTH and log-transformed RTE (P = 0.030, P for non-linearity = 0.124). However, the serum levels of FGF23 and ALP were not associated with RTE. In patients with CKD, serum PTH concentrations were related to thymic atrophy which contributes to immune abnormality.Kenichiro IioDaijiro KabataRei IioYosuke ImaiMasaki HatanakaHiroki OmoriYoshihiko HoshidaYukihiko SaekiAyumi ShintaniTakayuki HamanoYoshitaka IsakaYutaka AndoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kenichiro Iio
Daijiro Kabata
Rei Iio
Yosuke Imai
Masaki Hatanaka
Hiroki Omori
Yoshihiko Hoshida
Yukihiko Saeki
Ayumi Shintani
Takayuki Hamano
Yoshitaka Isaka
Yutaka Ando
Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
description Abstract Premature immune ageing, including thymic atrophy, is observed in patients with chronic kidney disease (CKD). Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23), which are mineral and bone disorder (MBD)-related factors, affect immune cells and possibly cause thymic atrophy. We examined the cross-sectional association between thymic atrophy, evaluated as the number of CD3+CD4+CD45RA+CD31+ cells [recent thymic emigrants (RTE)/μL], and MBD-related factors [(serum PTH, FGF23, and alkaline phosphatase (ALP) level] in 125 patients with non-dialysis dependent CKD. Median estimated glomerular filtration rate (eGFR) was 17 mL/min/1.73 m2. Older age (r = −0.46), male sex (r = −0.34), lower eGFR (r = 0.27), lower serum-corrected calcium (r = 0.27), higher PTH (r = −0.36), and higher ALP level (r = −0.20) were identified as determinants of lower number of RTE. In contrast, serum concentrations of FGF23 and phosphorus were not correlated with RTE. Multivariate non-linear regression analysis indicated a negative association between serum PTH and log-transformed RTE (P = 0.030, P for non-linearity = 0.124). However, the serum levels of FGF23 and ALP were not associated with RTE. In patients with CKD, serum PTH concentrations were related to thymic atrophy which contributes to immune abnormality.
format article
author Kenichiro Iio
Daijiro Kabata
Rei Iio
Yosuke Imai
Masaki Hatanaka
Hiroki Omori
Yoshihiko Hoshida
Yukihiko Saeki
Ayumi Shintani
Takayuki Hamano
Yoshitaka Isaka
Yutaka Ando
author_facet Kenichiro Iio
Daijiro Kabata
Rei Iio
Yosuke Imai
Masaki Hatanaka
Hiroki Omori
Yoshihiko Hoshida
Yukihiko Saeki
Ayumi Shintani
Takayuki Hamano
Yoshitaka Isaka
Yutaka Ando
author_sort Kenichiro Iio
title Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
title_short Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
title_full Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
title_fullStr Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
title_full_unstemmed Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
title_sort parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/78e139fff6524f55999681e7229fc591
work_keys_str_mv AT kenichiroiio parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT daijirokabata parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT reiiio parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT yosukeimai parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT masakihatanaka parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT hirokiomori parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT yoshihikohoshida parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT yukihikosaeki parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT ayumishintani parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT takayukihamano parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT yoshitakaisaka parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
AT yutakaando parathyroidhormoneandprematurethymusageinginpatientswithchronickidneydisease
_version_ 1718388068068622336